Abstract
When reported in publications, sample size calculations and statistical methods were often explicitly discrepant with the protocol or not pre-specified. Such amendments were rarely acknowledged in the trial publication. The reliability of trial reports cannot be assessed without having access to the full protocols.
Keywords
Affiliated Institutions
Related Publications
Statistical Problems in the Reporting of Clinical Trials
Reports of clinical trials often contain a wealth of data comparing treatments. This can lead to problems in interpretation, particularly when significance testing is used exten...
Applying results of randomised trials to clinical practice: impact of losses before randomisation.
The problem of generalisability in randomised clinical trials was highlighted by studies that entered only 10-14% of screened patients. To determine the magnitude and source of ...
Adverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials
Purpose Prospectively planned collection and analysis of adverse event (AE) data are essential parts of well-conducted clinical trials. The AE data in a trial sponsor's database...
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary g...
Interim analysis: The alpha spending function approach
Abstract Interim analysis of accumulating data in a clinical trial is now an established practice for ethical and scientific reasons. Repeatedly testing interim data can inflate...
Publication Info
- Year
- 2008
- Type
- article
- Volume
- 337
- Issue
- dec04 1
- Pages
- a2299-a2299
- Citations
- 195
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1136/bmj.a2299